Select Publications
Journal articles
2024, 'Chemotherapy and radiotherapy for advanced pancreatic cancer', Cochrane Database of Systematic Reviews, 2024, http://dx.doi.org/10.1002/14651858.CD011044.pub3
,2024, 'Application of a revised model for coping with advanced cancer to qualitatively explore lung cancer survivors’ experiences of ongoing physical effects, novel treatments, uncertainty, and coping', Journal of Cancer Survivorship, 18, pp. 1754 - 1770, http://dx.doi.org/10.1007/s11764-023-01417-x
,2024, 'STEM-01. SHARED ASTROCYTE-LIKE GLIOMA STEM CELLS DRIVE HETEROGENEITY AND IMMUNE DYNAMICS IN ADULT-TYPE DIFFUSE GLIOMAS', Neuro-Oncology, 26, pp. viii57 - viii57, http://dx.doi.org/10.1093/neuonc/noae165.0227
,2024, 'A BRAIN CANCER CELL ATLAS REVEALS SHARED ASTROCYTE-LIKE STEM CELL STATES DRIVE INTRATUMOURAL HETEROGENEITY AND SHAPE IMMUNE DYNAMICS IN ADULT-TYPE DIFFUSE GLIOMAS', NEURO-ONCOLOGY, 26, pp. V3 - V3, http://dx.doi.org/10.1093/neuonc/noae144.007
,2024, 'Impact of COVID-19 on lung cancer care in New South Wales, Australia: real-world data from the EnRICH Program', Public Health Research and Practice, 34, http://dx.doi.org/10.17061/phrp3432423
,2024, 'ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance', JTO Clinical and Research Reports, 5, http://dx.doi.org/10.1016/j.jtocrr.2024.100703
,2024, 'Onkolytische Viren zur Verstärkung der PD-1-Hemmung bei metastasierendem kutanem Plattenepithelkarzinom', JDDG - Journal of the German Society of Dermatology, 22, pp. 1016 - 1019, http://dx.doi.org/10.1111/ddg.15423_g
,2024, 'Predicting immunotherapy toxicity through single-cell sequencing of peripheral immune cells: A pilot study.', Journal of Clinical Oncology, 42, pp. e14538 - e14538, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e14538
,2024, 'Brief Report: Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma—RIOMeso', Journal of Thoracic Oncology, 19, pp. 636 - 642, http://dx.doi.org/10.1016/j.jtho.2023.11.014
,2024, 'Development of clinically meaningful quality indicators for contemporary lung cancer care, and piloting and evaluation in a retrospective cohort; experiences of the Embedding Research (and Evidence) in Cancer Healthcare (EnRICH) Program', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-074399
,2024, 'Carrying on with life as a lung cancer survivor: a qualitative study of Australian survivors’ employment, finances, relationships, and healthcare experiences', Translational Lung Cancer Research, 13, pp. 785 - 798, http://dx.doi.org/10.21037/tlcr-23-815
,2024, '675P Assessing later-line treatment strategies and outcomes in EGFR oncogene-driven stage IV non-small cell lung cancer', Annals of Oncology, 35, pp. S1657 - S1657, http://dx.doi.org/10.1016/j.annonc.2024.10.708
,2024, 'Oncolytic viruses to augment PD-1 inhibition in metastatic cutaneous squamous cell carcinoma', JDDG - Journal of the German Society of Dermatology, 22, pp. 1016 - 1018, http://dx.doi.org/10.1111/ddg.15423
,2024, 'P1.03D.09 Single Cell RNA Sequencing and Functional Monocyte Stimulation Reveals Phenotypic Predispositions to Developing Lung Cancer in Never Smokers', Journal of Thoracic Oncology, 19, pp. S155 - S156, http://dx.doi.org/10.1016/j.jtho.2024.09.281
,2024, 'Safety and Tolerability of Magrolimab Combination Therapy in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (RM-HNSCC)', International Journal of Radiation Oncology*Biology*Physics, 118, pp. e85 - e86, http://dx.doi.org/10.1016/j.ijrobp.2024.01.190
,2023, 'Transitioning single-cell genomics into the clinic', Nature Reviews Genetics, 24, pp. 573 - 584, http://dx.doi.org/10.1038/s41576-023-00613-w
,2023, 'A phase 2 study of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma: ELEVATE HNSCC.', Journal of Clinical Oncology, 41, pp. TPS6102 - TPS6102, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.tps6102
,2023, 'A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma', Cancer Medicine, 12, pp. 11234 - 11247, http://dx.doi.org/10.1002/cam4.5815
,2023, 'Air pollution and lung cancer—A new era', Respirology, 28, pp. 313 - 315, http://dx.doi.org/10.1111/resp.14464
,2023, 'Two Very Rare Cases of Metastatic Thymic Carcinoma with Sjogren's Syndrome: A Case Series', Case Reports in Oncology, 16, pp. 122 - 129, http://dx.doi.org/10.1159/000529425
,2023, 'Immune checkpoint inhibitors for advanced pancreatic cancer', Cochrane Database of Systematic Reviews, 2023, http://dx.doi.org/10.1002/14651858.CD014523
,2023, 'Clinicians' Evaluation of Lung Cancer Clinical Quality Indicators and Comparative Performance Data in Practice', European Journal of Cancer Care, 2023, http://dx.doi.org/10.1155/2023/6636704
,2023, 'MA17.05 Real World Outcomes of Immunotherapy (IO) for Pleural MESOthelioma in Australia - RIOMeso', Journal of Thoracic Oncology, 18, pp. S163 - S163, http://dx.doi.org/10.1016/j.jtho.2023.09.239
,2023, 'P2.10-01 ALKTERNATE: A Pilot Study Alternating Lorlatinib with Crizotinib in Patients with ALK+ NSCLC and ALK-inhibitor Resistance', Journal of Thoracic Oncology, 18, pp. S351 - S352, http://dx.doi.org/10.1016/j.jtho.2023.09.616
,2022, 'High cyclin E1 protein, but not gene amplification, is prognostic for basal-like breast cancer', Journal of Pathology: Clinical Research, 8, pp. 355 - 370, http://dx.doi.org/10.1002/cjp2.269
,2022, 'Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review', Immunotherapy, 14, pp. 511 - 520, http://dx.doi.org/10.2217/imt-2021-0225
,2022, 'Activin-A, Growth Differentiation Factor-11 and Transforming Growth Factor-β as predictive biomarkers for platinum chemotherapy in advanced non-small cell lung cancer', Cancer Treatment and Research Communications, 32, http://dx.doi.org/10.1016/j.ctarc.2022.100576
,2022, 'EP10.01-005 Australian Lung Cancer Survivors Experiences of Novel Treatments, Healthcare, and Ongoing Physical and Psychological Needs', Journal of Thoracic Oncology, 17, pp. S502 - S502, http://dx.doi.org/10.1016/j.jtho.2022.07.882
,2022, 'EP16.03-041 Single Cell RNA Sequencing Reveals Phenotypic Predispositions to Developing Lung Cancer in Never-Smokers', Journal of Thoracic Oncology, 17, pp. S608 - S608, http://dx.doi.org/10.1016/j.jtho.2022.07.1102
,2021, 'A single-cell tumor immune atlas for precision oncology', Genome Research, 31, pp. 1913 - 1926, http://dx.doi.org/10.1101/gr.273300.120
,2021, 'Pharmacologic and radiotherapeutic interventions for advanced pancreatic cancer', Cochrane Database of Systematic Reviews, 2021, http://dx.doi.org/10.1002/14651858.CD010584.pub2
,2021, 'Altered presentation of oropharyngeal cancer, a 6-year review', ANZ Journal of Surgery, 91, pp. 1240 - 1245, http://dx.doi.org/10.1111/ans.16537
,2021, 'A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinoma', eLife, 10, http://dx.doi.org/10.7554/eLife.65234
,2021, 'Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer', Gastroenterology, 160, pp. 362 - 377.e13, http://dx.doi.org/10.1053/j.gastro.2020.09.043
,2021, 'P24.03 Dynamic Circulating Tumor DNA Interim Results From The ALKternate Clinical Trial', Journal of Thoracic Oncology, 16, pp. S1030 - S1032, http://dx.doi.org/10.1016/j.jtho.2021.08.368
,2021, 'P37.19 Activin-A and GDF-11 as Predictive Biomarkers for Platinum Response in Non-Small Cell Lung Cancer', Journal of Thoracic Oncology, 16, pp. S450 - S450, http://dx.doi.org/10.1016/j.jtho.2021.01.766
,2021, 'P60.01 Single-Cell Transcriptomics to Assess Response to Immunotherapy in Advanced Lung Cancer ex-vivo: Developing a Functional Predictive Assay', Journal of Thoracic Oncology, 16, pp. S540 - S541, http://dx.doi.org/10.1016/j.jtho.2021.01.960
,2020, 'Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer', Annals of Surgery, 272, pp. 366 - 376, http://dx.doi.org/10.1097/SLA.0000000000003143
,2020, 'Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma', eLife, 9, pp. 1 - 25, http://dx.doi.org/10.7554/eLife.53367
,2020, 'Activin as a biomarker for platinum resistance in non-small cell lung cancer.', Journal of Clinical Oncology, 38, pp. e21737 - e21737, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e21737
,2020, 'HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer', Cell Reports, 31, http://dx.doi.org/10.1016/j.celrep.2020.107625
,2020, 'The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies', Cancer Immunology, Immunotherapy, 69, pp. 343 - 354, http://dx.doi.org/10.1007/s00262-019-02453-2
,2020, 'Nutritional parameters associated with hospital admissions in patients being treated for head and neck cancer', Supportive Care in Cancer, 28, pp. 341 - 349, http://dx.doi.org/10.1007/s00520-019-04826-w
,2020, 'A Non-Genetic, Cell Cycle Dependent Mechanism of Platinum Resistance in Lung Adenocarcinoma', , http://dx.doi.org/10.1101/2020.11.26.400499
,2019, 'Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer', Oncogene, 38, pp. 1661 - 1675, http://dx.doi.org/10.1038/s41388-018-0536-1
,2019, 'Durvalumab-induced diabetic ketoacidosis followed by hypothyroidism', Endocrinology, Diabetes and Metabolism Case Reports, 2019, http://dx.doi.org/10.1530/EDM-19-0098
,2019, 'Cyclin E1 is a shared biomarker of subsets of high grade serous ovarian cancer (HGSOC) and basal like breast cancer (BLBC)', Annals of Oncology, 30, pp. ix86 - ix86, http://dx.doi.org/10.1093/annonc/mdz426.029
,2018, 'Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer', Gut, 67, pp. 2142 - 2155, http://dx.doi.org/10.1136/gutjnl-2017-315144
,2018, 'Prospective Evaluation of the Clinical Utility of the International Lung Screen Trial Lung Nodule Management Protocol', JOURNAL OF THORACIC ONCOLOGY, 13, pp. S362 - S363, http://dx.doi.org/10.1016/j.jtho.2018.08.332
,2018, 'MASTL overexpression promotes chromosome instability and metastasis in breast cancer', Oncogene, 37, pp. 4518 - 4533, http://dx.doi.org/10.1038/s41388-018-0295-z
,